Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 6.17B P/E - EPS this Y 15.10% Ern Qtrly Grth -
Income -616.43M Forward P/E -13.10 EPS next Y 10.10% 50D Avg Chg 7.00%
Sales 54k PEG 0.58 EPS past 5Y - 200D Avg Chg 41.00%
Dividend N/A Price/Book 9.14 EPS next 5Y -20.20% 52W High Chg -
Recommedations 2.70 Quick Ratio 8.31 Shares Outstanding 61.66M 52W Low Chg 120.00%
Insider Own 0.27% ROA -34.53% Shares Float 61.52M Beta 0.55
Inst Own 83.86% ROE -70.30% Shares Shorted/Prior 6.02M/5.11M Price 99.99
Gross Margin - Profit Margin - Avg. Volume 1,472,638 Target Price 97.86
Oper. Margin -1,010,483.30% Earnings Date Aug 3 Volume Change 0.00%

Arena Pharmaceuticals, Inc., a biopharmaceutical company, focuses on providing novel medicines with pharmacology and pharmacokinetics to patients worldwide. The company's investigational clinical programs include Etrasimod (APD334) that is in Phase III clinical trial for ulcerative colitis, Phase IIb/III clinical trial for Crohn's disease, Phase II clinical trial for alopecia areata, Phase III clinical trial for atopic dermatitis, and Phase IIb clinical trial for eosinophilic esophagitis; Olorinab (APD371), which is in Phase IIb clinical trial for the treatment of abdominal pain associated with irritable bowel syndrome; APD418 that is in Phase II clinical trial for acute heart failure; and Temanogrel for coronary microvascular obstruction that is in Phase II clinical trial. It also develops ralinepag (APD811), which is in Phase III clinical trial for pulmonary arterial hypertension. The company has collaboration agreements with United Therapeutics Corporation; Everest Medicines Limited; Eisai Co., Ltd. and Eisai Inc.; Boehringer Ingelheim International GmbH; Beacon Discovery, Inc.; and Aristea Therapeutics, Inc. Arena Pharmaceuticals, Inc. was incorporated in 1997 and is based in Park City, Utah. As of March 11, 2022, Arena Pharmaceuticals, Inc. operates as a subsidiary of Pfizer Inc.

ARNA Chatroom

User Image Nostradamus696 Posted - 2 weeks ago

$BLUE this company gives me chills. As a long time biotech investor the chart pattern has all the hallmarks of an imminent buyout. Gives me fond memories of $TRIL $ARNA $BHVN. Looking at the 5 year chart, short interest, imminent catalysts with our 2nd FDA approval around the corner. If buyout does not transpire, this will multi bag like a $BCRX

User Image Tuong_L_J Posted - 1 month ago

$SRNE $ARNA Was a company that was winding down. Board members voted out with a completely restructured company. Look where they are now bought by Pfizer! If the same CEO replaces Ji the SP will shoot up. Kick HANK off the board

User Image Nostradamus696 Posted - 1 month ago

$BLUE price action reminds me so much of $ARNA $CCXI $TRIL and a number of others I have been in that have been acquired. Convinced that it is not a matter of if but a matter of when. Any intelligent suitor would offer before FDA approval for second indication in September. ULTRA BULLISH!!!

User Image Galacticon Posted - 1 month ago

$SPPI this one has a lot of similar patterns to $ARNA which got bought out by $PFE . I was in only at 2500 shares…regret was that I didn’t have more!

User Image bigwhalealert Posted - 1 month ago

$ARNA BUY/SELL METER Alert Cross 31% + 🚀 https://t8sk.com/ARNA

User Image arfarfman Posted - 1 month ago

$SELB wild! My best performing stock year to date +230% congrats to everyone here who has held on from the .60-.70s. I sold half around 1.40 because that was a double for me but holding the rest forever. $SRPT anD $ARNA for me were very similar plays and holds that paid huge years later. Got the same anticipation here. What are you all doing with your positions?

User Image hoyeseldia Posted - 07/27/22

$GNLN Jun 24 = $0,42 Jun 27 = $0,25 Jun 30 = $0,21 Jul 18 = $0,19 Jul 22 = $0,17 Jul 26 = $0,146 Market cap = only 15M 52 week high $3,80 News (not bad) Jun 22- Announces Update on Plan to Generate $30 Million in Non-Dilutive Liquidity Jun 24 - Announced Begins Shipping Electronic Nicotine Delivery Systems (ENDS) Products to B2B Clients Via USPS Exemption Jun 27 - Announced $5.4 Million Registered Direct Offering at $0.25 Jul 19 - Announced $5.3 million in cash from sale of stake in VIBES squeeze is coming !! tic tac tic tac Attention to $SNDL , $ARNA , $KERN and $ACB cannabis power!!

User Image macroaxis Posted - 2 months ago

$ARNA - Option Volatility signal: Arena Pharmaceuticals pin risk is slipping https://www.macroaxis.com/stock-options/ARNA/Arena-Pharmaceuticals?utm_source=dlvr.it&utm_medium=stocktwits

User Image hoyeseldia Posted - 2 months ago

$GNLN $0,205 , straight to $0,3X in two weeks With this news it reached $0.42 on Friday 24/06.... GREENLANE BEGINS SHIPPING ELECTRONIC NICOTINE DELIVERY SYSTEMS (ENDS) PRODUCTS TO B2B CLIENTS VIA USPS EXEMPTION Attention: $KERN , $ACB , $ARNA , $CGC up up up to the moon https://investor.gnln.com/news-events/press-releases/detail/99/greenlane-begins-shipping-electronic-nicotine-delivery

User Image macroaxis Posted - 3 months ago

$ARNA - Option Volatility signal: Arena Pharmaceuticals pin risk is slipping https://www.macroaxis.com/stock-options/ARNA/Arena-Pharmaceuticals?utm_source=dlvr.it&utm_medium=stocktwits

User Image Quantumup Posted - 3 months ago

Credit Suisse~Keeps Outperform/$52PT $RXDX Enrollment Update Indicates IBD Trials On Track: biologics have historically demonstrated placebo-adjusted CR rates in low to upper teens. More recently, $pfe $arna S1PR modulator etrasimod achieved placebo-adjusted CRs of ~20%/~10% at week 12 in its two P3 trials, with significant variability across the two trials owing to wide ranging placebo responses (7.4% and 15.2%, respectively). Rating is based on a blended, risk-adjusted, product-based DCF, assessing the company as a standalone entity ($41, 50% weighting) and as a potential M&A candidate ($62, 50% weighting). /applying a 35% PoS for lead program PRA023 in Ulcerative Colitis /20% PoS for PRA023 in Crohn's Disease Blue Sky scenario of $100 assumes substantial de-risking of lead program PRA023 in UC and CD based on positive PoC data, and reflects a program PoS of 70% in UC and 50% in CD, plus additional pipeline return and M&A value Early Enrollment points2 a good thing. IMO

User Image OuAce76 Posted - 4 months ago

$MNKD There was someone named Spencer O., that use to write articles regarding Mannkind, that kept saying Mannkind should follow the same kind of path that $ARNA Arena Pharmaceuticals was on. His vision for Mannkind was to sell off approved treatments and develop the pipeline. I just looked up Arena Pharmaceuticals to see what they are up to these days and it looks like the got bought out by Pfizer in March 2022 for $6.7 billion. Wouldn’t that make Mannkind around $25 a share if it was to be bought out at a similar valuation?

User Image inv1ncible Posted - 5 months ago

$CLVS $arna did a 10 for 1 reverse split back in 2017 and got bought out by $PFE in 2021 for $100

User Image RaffiSosikian Posted - 03/31/22

Price stats of the last 12 Thursdays, based on the last hour of trading https://pinnaclequant.com/price-action-stats-last-12-thursdays-aapl-amc-amzn-arna/ Stats generated for: $AAPL $AMC $AMZN $ARNA

User Image RaffiSosikian Posted - 03/30/22

Price action stats of the last 12 Wednesdays, based on the last hour of trading https://pinnaclequant.com/price-action-stats-last-12-wednesdays-amc-amzn-arna-axp/ Stats generated for: $AMC $AMZN $ARNA $AXP

User Image HoneyFitzIVXX Posted - 03/29/22

$SNDL $TLRY $HEXO This article from. 2019 is suddenly important again after Senator Feinstein’s press release. Remember Trump said Pfizer owns the FDA, then $PFE purchase $ARNA for $6.7bb? https://pubmed.ncbi.nlm.nih.gov/30919712/ So now Pfizer is in the weed sector and they own the FDA, and now Feinstein is pushing it at the FDA. #swampy link to Feinstein PR ==>> https://www.feinstein.senate.gov/public/index.cfm/press-releases?id=7A3020FD-4E3B-46E5-83E9-89BF12450C96

User Image ItTakesItAll Posted - 03/29/22

$MEIP how much MEIP is worth if $ARNA was take over by $PFE for 6.7B, $100 shares with 54K revenue, a lot of debit and promising pipeline ? https://finance.yahoo.com/m/4e4a0ae5-464c-398e-81c6-bd18d57de19c/pfizer-stock-up-arena-stock.html

User Image RaffiSosikian Posted - 03/29/22

Price action stats of the last 12 Tuesdays, based on the last hour of trading https://pinnaclequant.com/price-action-stats-last-12-tuesdays-aapl-arna-axp-ba/ Stats generated for: $AAPL $ARNA $AXP $BA

User Image futuretilray Posted - 5 months ago

$TLRY $PFE finished acquisition of $ARNA on March 11, 2022. Shows the healthcare industry inroads into cannabis and healthcare.

User Image RaffiSosikian Posted - 6 months ago

Price action stats of the last 12 Fridays, based on the last hour of trading https://pinnaclequant.com/price-action-stats-last-12-fridays-aapl-amc-amzn-arna/ Stats generated for: $AAPL $AMC $AMZN $ARNA

User Image RaffiSosikian Posted - 6 months ago

Price action stats of the last 12 Thursdays, based on the last hour of trading https://pinnaclequant.com/price-action-stats-last-12-thursdays-aapl-amc-arna-axp/ Stats generated for: $AAPL $AMC $ARNA $AXP

User Image Stockman824 Posted - 6 months ago

$PAVM let’s not forget this. I was invested in $ARNA Arena Pharmaceuticals for 7 years of crazy ups and downs. The CEO was a slime ball but they had some outstanding drugs in Phase 2 and 3. It was recently Bought out basically for 1 drug in Phase 3 trials. It wasn’t even approved, it just showed its phase 3 results which were outstanding. Pfizer bought the company for SEVEN Billion FOR ONE DRUG imagine how much PavMed and $LUCD will be worth in 1 year in 2 years!!!! HOLD TIGHT

User Image cctranscripts Posted - 6 months ago

Securities registration termination [Section 12(g)] https://www.conferencecalltranscripts.com/summary/?id=10596446 $ARNA

User Image risenhoover Posted - 6 months ago

$ARNA / Arena Pharmaceuticals files form 15-12G https://fintel.io/sf/us/arna?utm_source=stocktwits.com&utm_medium=Referral&utm_campaign=filing

User Image Quantisnow Posted - 6 months ago

$ARNA 📜 SEC Form 15-12G filed by Arena Pharmaceuticals Inc. https://quantisnow.com/i/2599408?utm_source=stocktwits 45 seconds delayed.

User Image fla Posted - 6 months ago

$ARNA [15s. delayed] filed form 15-12G on March 21, 06:03:29 https://s.flashalert.me/9wZG1A

User Image Newsfilter Posted - 6 months ago

$ARNA Form 15-12G (securities registration termination [section 12(g)]) filed with the SEC https://newsfilter.io/a/eef9288189b130e1280f678500850dd6

User Image macroaxis Posted - 6 months ago

$ARNA - Next earnings report is on 4th of May 2022. #stocks #earnings

User Image Galacticon Posted - 6 months ago

$ARNA hoping this gets shorted!

User Image Newsfilter Posted - 6 months ago

$ARNA A Study to Evaluate Etrasimod Treatment in Adolescents With Ulcerative Colitis - NCT05287126 https://newsfilter.io/a/ce7802636e604efc675fb84bf8b12fc8

Analyst Ratings
HC Wainwright & Co. Neutral Feb 9, 22
Cantor Fitzgerald Neutral Dec 21, 21
Citigroup Neutral Dec 14, 21
JMP Securities Market Perform Dec 14, 21
SVB Leerink Market Perform Dec 14, 21
RBC Capital Sector Perform Dec 14, 21
Credit Suisse Neutral Dec 14, 21
Jefferies Hold Dec 14, 21
Needham Hold Dec 13, 21
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Dallas Jayson Donald Alexander Director Director Jun 15 Sell 66.36 1,223 81,158 7,152 06/15/21
Lisicki Robert EVP, Chief Commercia.. EVP, Chief Commercial Officer Feb 04 Option 40.95 17,500 716,625 26,941 02/04/21
Lisicki Robert EVP, Chief Commercia.. EVP, Chief Commercial Officer Feb 04 Sell 78.52 17,500 1,374,100 9,441 02/04/21
Munshi Amit President and CEO President and CEO Jan 20 Option 15.5 100,000 1,550,000 57,750 01/20/21
Munshi Amit President and CEO President and CEO Jan 20 Sell 80.46 100,000 8,046,000 7,750 01/20/21
Munshi Amit President and CEO President and CEO Jan 14 Sell 74.87 14,877 1,113,841 7,750 01/14/21
Lisicki Robert EVP, Chief Commercia.. EVP, Chief Commercial Officer Dec 03 Sell 65.88 3,872 255,087 12/03/20